Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
rosacea eczema alopecia ceramide keratosis pityriasis basal cell melanoma keratosis purpuraYour Article Summary
See Latest ArticlesIncreased expression of IL-12p70 and IL-23 by multiple dendritic cell and macrophage subsets in plaque psoriasis
Journal of Dermatological Science, 04/09/09
Yawalkar N et al. - Bioactive forms of IL-12 and IL-23 are highly expressed in various DC and macrophage subsets and their marked in situ production suggest that both cytokines have crucial pathogenic role in psoriasis.
Related Articles
FDA Approves New Drug to Treat Psoriasis
Internet Source, 11/02/09
Relevance Score: 91%
Lack of association between angiotensin I-converting enzyme insertiondeletion polymorphism and psoriasis or psoriatic arthritis in Spain
International Journal of Dermatology, 11/30/09
Relevance Score: 89%
Long-term efalizumab therapy for patients with moderate-to-severe, chronic plaque psoriasis
International Journal of Dermatology, 11/25/09
Relevance Score: 89%
Methotrexate versus traditional Chinese medicine in psoriasis: a randomized, placebo-controlled trial to determine efficacy, safety and quality of life
Clinical and Experimental Dermatology, 11/25/09
Relevance Score: 89%
Scalp psoriasis: European consensus on grading and treatment algorithm
Journal of the European Academy of Dermatology and Venereology, 11/24/09
Relevance Score: 89%
Today in Psoriasis...keeping you current
Receive free subspecialty "5-minute updates" via email
Development and validation of nail psoriasis quality of life scale (NPQ10)
Journal of the European Academy of Dermatology and Venereology, 12/16/09
Efficacy and Safety of Efalizumab in Patients with Moderate-to-Severe Plaque Psoriasis Resistant to Previous Anti-Psoriatic Treatment: Results of a Multicentre, Open-label, Phase IIIb/IV Trial
Archives of Drug Information, 12/08/09
Analysis of psoriatic patients registered in Asahikawa Medical College Hospital from 1983 to 2007
Journal of Dermatology, 12/08/09
Sponsor
Article Search
Sponsor
Sponsor